Literature DB >> 6315671

Alkalinization of the intralysosomal pH by clindamycin and its effects on neutrophil function.

M S Klempner, B Styrt.   

Abstract

Clindamycin is concentrated within human neutrophils and their lysosomes because the intralysosomal pH is highly acidic and this antibiotic behaves as a weak base. We have examined the ability of clindamycin to buffer (alkalinize) the intralysosomal pH and studied the consequences of alterations of lysosomal pH on neutrophil functions. At therapeutic concentrations of clindamycin (0.01 mM), we observed no effect on intralysosomal pH as monitored by the distribution and fluorescence of a weakly basic fluorescent probe 9-aminoacridine. However, at higher concentrations (1.0 mM), clindamycin alkalinized the intralysosomal pH and inhibited neutrophil lysosomal degranulation to several stimuli, and superoxide production in response to phorbol myristate acetate. Neutrophil locomotion was unaffected even at concentrations of clindamycin which increased the intralysosomal pH. We conclude that clindamycin accumulates in acidic neutrophil lysosomes and, at high concentrations, alkalinizes the intralysosomal pH. Coincident with lysosomal alkalinization there is inhibition of secretion and respiratory burst activity suggesting that intact lysosomal pH regulation is important for these functions. Clindamycin provides a useful tool to examine the relationships between weak base uptake, lysosomal pH and neutrophil functions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6315671     DOI: 10.1093/jac/12.suppl_c.39

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Clindamycin inhibits nociceptive response by reducing tumor necrosis factor-α and CXCL-1 production and activating opioidergic mechanisms.

Authors:  Felipe F Rodrigues; Marcela I Morais; Ivo S F Melo; Paulo S A Augusto; Marcela M G B Dutra; Sarah O A M Costa; Fábio C Costa; Franciele A Goulart; Alysson V Braga; Márcio M Coelho; Renes R Machado
Journal:  Inflammopharmacology       Date:  2019-11-25       Impact factor: 4.473

2.  Uptake of antibiotics by human polymorphonuclear leukocyte cytoplasts.

Authors:  W L Hand; N L King-Thompson
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

3.  In vivo potentiation of polymorphonuclear leukocyte chemotaxis by clindamycin.

Authors:  A T Skoutelis; P E Lianou; H P Bassaris
Journal:  Infection       Date:  1993 Sep-Oct       Impact factor: 3.553

4.  Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes.

Authors:  W L Hand; D L Hand; N L King-Thompson
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

5.  Comparative Efficacy of Different Oral Doses of Clindamycin in Preventing Post-Operative Sequelae of Lower Third Molar Surgery-A Randomized, Triple-Blind Study.

Authors:  Anna Janas-Naze; Gaja Torbicka; Damian Chybicki; Małgorzata Lipczyńska-Lewandowska; Wei Zhang
Journal:  Medicina (Kaunas)       Date:  2022-05-17       Impact factor: 2.948

6.  Quinine uptake by human polymorphonuclear neutrophils.

Authors:  J el Benna; C Pasquier; M T Labro
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

7.  Enhancement of antibiotic concentrations in gastric mucosa by H2-receptor antagonist. Implications for treatment of Helicobacter pylori infections.

Authors:  T U Westblom; D E Duriex
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.